MedTrace Logo

Clinical Trials

NCT05721248 | ACTIVE_NOT_RECRUITING | PHASE2
82 participants

STOP-HER2: Stopping Trastuzumab in HER2+ MBC

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2023-04-19
Completion:
2026-06-22
Conditions
  • Breast Cancer
  • Metastatic Breast Cancer
  • HER2-positive Breast Cancer
Interventions
  • OTHER
No Results Yet
NCT05699642 | COMPLETED | PHASE2
70 participants

Online Tai Chi Plus Fitbit After ACS

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2024-08-27
Completion:
2026-07-01
Conditions
  • Acute Coronary Syndrome
  • Physical Inactivity
Interventions
  • BEHAVIORAL
No Results Yet
NCT05636020 | ACTIVE_NOT_RECRUITING | NA
85 participants

Intervention to Change Affect Recognition and Empathy

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2023-03-15
Completion:
2027-02-28
Conditions
  • Traumatic Brain Injury
  • Concussion, Intermediate
  • Concussion, Severe
  • Concussion With LOC 31 to 59 Minutes
  • Concussion With Brief Loss of Consciousness
  • Traumatic Brain Injury With Brief Loss of Consciousness
  • Traumatic Brain Injury With Loss of Consciousness
  • Traumatic Brain Injury With Prolonged Loss of Consciousness
  • Traumatic Brain Injury (TBI); Concussion, Initial Encounter
  • Traumatic Brain Injury (TBI); Concussion, Subsequent Encounter
  • Traumatic Brain Injury With No Loss of Consciousness
  • Traumatic Brain Injury With Open Intracranial Wound
  • Traumatic Brain Injury With Moderate Loss of Consciousness
Interventions
  • BEHAVIORAL
No Results Yet
NCT05581004 | ACTIVE_NOT_RECRUITING | PHASE1
165 participants

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2022-10-20
Completion:
2028-07-31
Conditions
  • Locally Advanced or Metastatic Solid Tumors
  • NSCLC
  • HNSCC
  • Melanoma
  • TNBC
  • Esophageal Cancer
  • Gastric Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Urothelial Carcinoma
  • Clear Cell RCC
  • HCC
Interventions
  • DRUG
No Results Yet
NCT05483868 | ACTIVE_NOT_RECRUITING | PHASE1
55 participants

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2022-09-26
Completion:
2027-03-31
Conditions
  • Non-muscle-invasive Bladder Cancer
  • NMIBC
  • Non-Muscle Invasive Bladder Carcinoma
  • Non-Muscle Invasive Bladder Neoplasms
  • Non-Muscle Invasive Bladder Urothelial Carcinoma
  • Urothelial Carcinoma Bladder
Interventions
  • DRUG
  • COMBINATION_PRODUCT
No Results Yet
NCT05398185 | ACTIVE_NOT_RECRUITING | NA
241 participants

WiseApp for Spanish Speakers Living With HIV

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2023-03-01
Completion:
2026-11-01
Conditions
  • HIV Infections
  • Acquired Immune Deficiency Syndrome
  • Sexually Transmitted Diseases, Viral
Interventions
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page